India  

Barclays, Yes Bank raise India inflation forecast as prices jump

IndiaTimes Thursday, 13 July 2023
India's inflation rose to a three-month high of 4.81% in June compared with 4.29% in May, due to surging prices of vegetables and pulses. This prompted economists to raise their forecasts for the year with Barclays now seeing consumer price inflation averaging at 5%, Yes Bank at 5.3%, and Emkay Global Financial Services at 5.2%.
0
shares
ShareTweetSavePostSend
 
Video Credit: Wibbitz Top Stories - Published
News video: Fed Expected to Continue Raising Rates Despite Inflation Easing

Fed Expected to Continue Raising Rates Despite Inflation Easing 01:31

Fed Expected to , Continue Raising Rates , Despite Inflation Easing. In June, inflation in the United States hit 3%, the lowest it has reached since March 2021. . NPR reports that the news could be a sign that the Federal Reserve's aggressive rate hikes have made a noticeable impact on the...

You Might Like


Related videos from verified sources

Survey Suggests US Households Remain Confident Despite Banking Instability [Video]

Survey Suggests US Households Remain Confident Despite Banking Instability

Survey Suggests , US Households Remain Confident , Despite Banking Instability. CNN reports that 2023 has been a strange time for mid-sized banks in the United States. Earlier this year, three..

Credit: Wibbitz Top Stories     Duration: 01:31Published
Key Inflation Rate Hits Lowest Annual Level in Almost 2 Years [Video]

Key Inflation Rate Hits Lowest Annual Level in Almost 2 Years

Key Inflation Rate , Hits Lowest Annual Level , in Almost 2 Years. CNBC reports that inflation continued to show signs of cooling in June, in line with Dow Jones estimates. CNBC reports that..

Credit: Wibbitz Top Stories     Duration: 01:31Published
Johnson & Johnson Joins Fight Against Lowering Drug Prices in the US [Video]

Johnson & Johnson Joins Fight Against Lowering Drug Prices in the US

Johnson & Johnson , Joins Fight Against Lowering , Drug Prices in the US. On July 18, Johnson & Johnson (J&J) became the third major pharmaceutical company to challenge the Biden administration's..

Credit: Wibbitz Top Stories     Duration: 01:30Published